ArticleClinical pharmacology and therapeutics2025

Semimechanistic Population PK/PD Modeling of Axatilimab in Healthy Participants and Patients With Solid Tumors or Chronic Graft-Versus-Host Disease.

Yan-Ou Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.